Cardiovascular Disease Monitoring and Diagnostic Devices – Global Strategic Business Report

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report …

Global Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts

The Global Diagnostics Partnering 2010-2017 report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading companies. Comprehensive directory of diagnostic deals since 2010 Diagnostic contract documents Diagnostic agreement terms Diagnostic agreement structure Top diagnostic deals by value Most active diagnostic dealmakers This report provides details of the …

Personalized Medicine – Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics,pharmacoproteomics, and metabolomics. Basic technologies of …

Fluoroscopy and Mobile C-Arms – Global Strategic Business Report

This report analyzes the worldwide markets for Fluoroscopy and Mobile C-Arms in US$ Thousand and Units by the following Segments: Fluoroscopy Equipment, and Mobile C-Arms (Full-Size C-Arms, & Mini C-Arms). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the …

Global Personalized Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts

The Global Personalized Medicine Partnering 2010-2017 report provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. This report provides details of the latest Personalized Medicine agreements announced in the life sciences since 2010. The report takes the reader through a comprehensive review …